GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (NYSE:MRK) » Definitions » Shiller PE Ratio

Merck (MRK) Shiller PE Ratio : 38.93 (As of Apr. 26, 2024)


View and export this data going back to 1949. Start your Free Trial

What is Merck Shiller PE Ratio?

As of today (2024-04-26), Merck's current share price is $131.20. Merck's E10 for the quarter that ended in Dec. 2023 was $3.37. Merck's Shiller PE Ratio for today is 38.93.

The historical rank and industry rank for Merck's Shiller PE Ratio or its related term are showing as below:

MRK' s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.56   Med: 26.85   Max: 39.37
Current: 38.93

During the past years, Merck's highest Shiller PE Ratio was 39.37. The lowest was 17.56. And the median was 26.85.

MRK's Shiller PE Ratio is ranked worse than
73.17% of 518 companies
in the Drug Manufacturers industry
Industry Median: 24.12 vs MRK: 38.93

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was $-0.480. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $3.37 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Merck Shiller PE Ratio Historical Data

The historical data trend for Merck's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck Shiller PE Ratio Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 39.15 31.30 26.05 32.35 32.38

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 30.13 35.01 29.75 32.38 -

Competitive Comparison of Merck's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Merck's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=131.20/3.37
=38.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Merck's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.48/129.4194*129.4194
=-0.480

Current CPI (Dec. 2023) = 129.4194.

Merck Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 0.570 99.695 0.740
201406 0.680 100.560 0.875
201409 0.310 100.428 0.399
201412 2.540 99.070 3.318
201503 0.330 99.621 0.429
201506 0.240 100.684 0.308
201509 0.640 100.392 0.825
201512 0.350 99.792 0.454
201603 0.400 100.470 0.515
201606 0.430 101.688 0.547
201609 0.780 101.861 0.991
201612 0.420 101.863 0.534
201703 0.560 102.862 0.705
201706 0.710 103.349 0.889
201709 -0.020 104.136 -0.025
201712 -0.323 104.011 -0.402
201803 0.270 105.290 0.332
201806 0.630 106.317 0.767
201809 0.730 106.507 0.887
201812 0.690 105.998 0.842
201903 1.120 107.251 1.352
201906 1.030 108.070 1.233
201909 0.740 108.329 0.884
201912 0.920 108.420 1.098
202003 1.260 108.902 1.497
202006 1.180 108.767 1.404
202009 1.160 109.815 1.367
202012 -0.830 109.897 -0.977
202103 1.250 111.754 1.448
202106 0.610 114.631 0.689
202109 1.800 115.734 2.013
202112 1.480 117.630 1.628
202203 1.700 121.301 1.814
202206 1.550 125.017 1.605
202209 1.280 125.227 1.323
202212 1.180 125.222 1.220
202303 1.110 127.348 1.128
202306 -2.350 128.729 -2.363
202309 1.860 129.860 1.854
202312 -0.480 129.419 -0.480

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Merck  (NYSE:MRK) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Merck Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Merck's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Executives
Johannes Jacobus Oosthuizen officer: SVP, U.S. Market 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Richard R. Deluca officer: EVP&Pres, Merck Animal Heallth 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Steven Mizell officer: EVP,Human Resources 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Joseph Romanelli officer: President, Human Health Int?l 126 EAST LINCOLN AVENUE, RAHWAY NJ 07065
Rita A Karachun officer: Sr. VP Fince-Global Controller 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jennifer Zachary officer: EVP, General Counsel 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
David Michael Williams officer: EVP,Chief Info&Digital Officer MERCK & CO., INC., 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Robert M Davis officer: Evp, Global Svcs & CFO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Sanat Chattopadhyay officer: Exe V-P & Pres. MMD 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Kenneth C Frazier officer: Chairman, President & CEO 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Chirfi Guindo officer: Chief Marketing Officer C/O BIOGEN INC., 225 BINNEY ST., CAMBRIDGE MA 02142
Baker Douglas M Jr director 370 WBASHA ST NORTH, ST PAUL MN 55102
Arpa Garay officer: SVP Human Health Global Mktg. 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Caroline Litchfield officer: EVP & CFO 2000 GALLOPING HILL RD, KENILWORTH NJ 07033
Julie L. Gerberding officer: EVP Strat Comm, GI Pub Policy 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033

Merck (MRK) Headlines

From GuruFocus

Q2 2022 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Q2 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc at ASCO Annual Meeting Transcript

By GuruFocus Research 01-23-2024

Q1 2023 Merck & Co Inc Earnings Call Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Investor Event at ACC.23/WCC Transcript

By GuruFocus Research 01-23-2024

Merck & Co Inc Annual Shareholders Meeting Transcript

By GuruFocus Research 01-23-2024